Bio-on was founded back in 2007 with its core technology based on patents filed by a group at the University of Hawaii. Seven years later, the company went public, and its activity (at least in the public eye) began to notably increase. By 2018, it claimed to have developed more than 100 applications for its PHAs, ranging from antifouling coatings to toys, with partners like AkzoNobel and Italeri. It also claimed to have licensed its technology with a granted capacity of more than 100,000 tons worldwide. Despite being a small company with limited resources, Bio-on continued to make announcements about new partnerships, licensing agreements, spinoffs, and product releases. Then, in July 2019, Bio-on was accused of fraud, including booking fraudulent revenues. Less than six months later, CEO Marco Astorrie resigned, the company's stock was delisted from the MIL, and the company was forced to cease payments to employees.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)